New drug approach offers hope for patients with recurrent aggressive cancers
Top Story
Archived
•
May 20, 2026
•
Merck announces that sac-TMT, a new cancer drug, demonstrated strong results in phase 3 trials for advanced or recurrent endometrial cancer patients.
Source: https://feeds.feedburner.com/foxnews/latest - Read Original
"What you put in is not always what you get out."
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!
Sponsored
"Output is a realization of Input."